tiprankstipranks
Sino Biopharmaceutical Ltd (HK:1177)
HKEX:1177
Holding HK:1177?
Track your performance easily

Sino Biopharmaceutical (1177) Ownership - Who Owns Sino Biopharmaceutical?

6 Followers

Sino Biopharmaceutical (1177) Ownership Overview

15.48%2.49%<0.01%4.90%77.12%
15.48% Insiders
<0.01% Other Institutional Investors
4.90% ETFs
77.12% Public Companies and
Individual Investors
The ownership structure of Sino Biopharmaceutical (HK:1177) stock is a mix of institutional, retail, and individual investors. Approximately 7.39% of the company’s stock is owned by Institutional Investors, 15.48% is owned by Insiders, and 77.12% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 04, 2024
Ping Tse
Vice Chairman
xxxxxxxxxxxxx
HK$51359460
Apr 23, 2024
Theresa Tse
Chairman
xxxxxxxxxxxxx
HK$5178200
Apr 22, 2024
Eric S Y Tse
Chief Executive Officer, >10% Owner
xxxxxxxxxxxxx
HK$11619500
Apr 19, 2024
Theresa Tse
Chairman
xxxxxxxxxxxxx
HK$5805750

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,658,904,241Insider8.83%719,964,441
887,034,750Insider4.72%384,973,082
377,675,905Institution2.01%163,911,343
357,557,270Insider1.90%155,179,855
308,110,862Institution1.64%133,720,114
151,061,412Institution0.80%65,560,653
135,687,818Institution0.72%58,888,513
58,920,495Institution0.31%25,571,495
50,376,756Institution0.27%21,863,512
46,534,000Institution0.25%20,195,756

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
151,061,412Institution0.80%65,560,653
135,687,818Institution0.72%58,888,513
58,920,495Institution0.31%25,571,495
46,534,000Institution0.25%20,195,756
17,499,662Institution0.09%7,594,853
12,203,000Institution0.06%5,296,102
9,496,647Institution0.05%4,121,545
8,749,000Institution0.05%3,797,066
4,523,500Institution0.02%1,963,199
3,066,000Institution0.02%1,330,644

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
135,564,818Institution0.72%61,582,650
125,703,444Institution0.67%57,102,951
89,868,000Institution0.48%38,884,459
27,307,000Institution0.15%11,815,306
23,918,750Institution0.13%10,349,264
24,395,500Institution0.13%10,249,091
24,395,500Institution0.13%10,249,091
19,368,718Institution0.10%8,798,569
18,712,000Institution0.10%7,861,326
17,063,500Institution0.09%7,383,106

FAQ

Who Owns Sino Biopharmaceutical Ltd (HK:1177)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 15.48% is held by insiders, and 77.12% is held by retail investors.
    What percentage of Sino Biopharmaceutical Ltd (HK:1177) stock is held by institutional investors?
    According to the latest TipRanks data, approximately <0.01% of Sino Biopharmaceutical Ltd (HK:1177) stock is held by institutional investors.
      What percentage of Sino Biopharmaceutical Ltd (HK:1177) stock is held by retail investors?
      According to the latest TipRanks data, approximately 77.12% of Sino Biopharmaceutical Ltd (HK:1177) stock is held by retail investors.
        Who owns the most shares of Sino Biopharmaceutical Ltd (HK:1177)?
        Ping Tse owns the most shares of Sino Biopharmaceutical Ltd (HK:1177).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis